Your Window on Drug Development and Innovation Worldwide
R&D Insight is a drug pipeline database that tracks and evaluates drugs worldwide through the entire development process, from discovery, through pre-clinical and clinical studies to launch. It delivers the industry’s most comprehensive combination of market and scientific drug development and innovation data.
The Value of Powerful Market and Competitive Analysis
- Monitor the progress of competitor’s R&D programs
- Evaluate the strengths and weaknesses of compounds
- Assess the commercial potential of upcoming products
- Access key scientific data to support licensing opportunities
- Review success/failure rates of companies or technologies
R&D Insight Delivers:
- An exhaustive compilation of drug programs worldwide, with drug profiles updated daily using information from company contacts, press releases, international conferences, company websites, and medical journals
- Alerting and tracking capabilities that keep you up-to-date on new treatments in development, significant clinical advances, and launch dates for new drugs
- Detailed scientific reviews of launched products and products in development, including pharmacokinetic and pharmacodynamic data, therapeutic studies, and adverse events to reveal the side effects and unique benefits of new treatments before they enter the market
- Commercial and financial forecasting data from our data partner, Credit Suisse.